About the Authors
- Emanuela Carlotti
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- David Wrench
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Guglielmo Rosignoli
-
Affiliation Flow Cytometry Core Facility, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Jacek Marzec
-
Affiliation Centre for Molecular Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Ajanthah Sangaralingam
-
Affiliation Centre for Molecular Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Lena Hazanov
-
Affiliation The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
- Miri Michaeli
-
Affiliation The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
- Simon Hallam
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Tracy Chaplin
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Sameena Iqbal
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Maria Calaminici
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Bryan Young
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- Ramit Mehr
-
Affiliation The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
- Peter Campbell
-
Affiliation Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom
- Jude Fitzgibbon
-
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
- John G. Gribben
-
* E-mail: j.gribben@qmul.ac.uk
Affiliation Centre for Haemato-Oncology, Barts Cancer Institute - a CR-UK Centre Of Excellence, Queen Mary University of London, London, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: EC JGG. Performed the experiments: EC DW GR TC. Analyzed the data: EC JM AS PC. Contributed reagents/materials/analysis tools: LH MM SI BY RM. Wrote the paper: EC JF JGG. Provided clinical/histopathological data: SH MC.